
Dydrovian 30mg Tablet CR
Marketer
Vivichem Pharma
Salt Composition
Dydrogesterone (30mg)
Overview Dydrovian 30mg Tablet CR
Progestin-30 CR (30mg) tablets are indicated for managing various progesterone-related disorders, including infertility, menstrual pain, premenstrual syndrome (PMS), endometriosis, irregular uterine bleeding, and recurrent miscarriage. It's also employed as hormone replacement therapy. Your physician will determine the appropriate prescription based on your individual diagnosis. Self-medication is strongly discouraged. Dosage and treatment length will be customized following examinations, such as blood work and ultrasounds. Maintain consistent daily intake to ensure regularity. Swallow the tablet whole with water; avoid crushing or chewing. Complete the prescribed course for optimal therapeutic results. Potential side effects include headache, nausea, uterine bleeding, and breast tenderness; intermenstrual bleeding may also occur. Consult your doctor regarding management strategies for these effects. Persistent or worsening symptoms require immediate medical attention. Prior to commencing treatment, disclose any pre-existing medical conditions, such as diabetes, depression, cardiovascular disease, or liver impairment. Similarly, inform your doctor of all current medications as interactions may compromise Progestin-30 CR efficacy. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Consult your physician for any further clarification or concerns.
Uses of Dydrovian 30mg Tablet CR
Managing infertility in women | Alleviating menstrual pain | Treating premenstrual syndrome (PMS) | Endometriosis care | Addressing abnormal uterine bleeding | Preventing pregnancy loss | Hormone replacement therapy
Major Benefits of Dydrovian 30mg Tablet CR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dydrovian 30mg Controlled-Release Tablets can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Dydrovian 30mg Tablet CR:
- Headache
- Nausea
- Breast pain
- Migraine
- Menstrual disorder
- Breast tenderness
- Vaginal bleeding
How to use Dydrovian 30mg Tablet CR:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dydrovian 30mg Controlled-Release tablet can be consumed with or without food, though consistent timing is recommended.
How Dydrovian 30mg Tablet CR works:
Progesterone-like actions are exhibited by the 30mg controlled-release Dydrovian tablet, mitigating hormonal imbalance symptoms. By preparing the uterine lining, it aids fertility treatment, regulating menstruation and reducing miscarriage risk. Consequently, it improves pregnancy prospects in women with recurrent pregnancy loss. Menstrual discomfort is also alleviated. Furthermore, Dydrovian 30mg CR inhibits endometrial tissue growth, easing endometriosis symptoms such as lower abdominal and back pain, dyspareunia, bowel irregularities, and subfertility.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining alcohol with a 30mg controlled-release Dydrovian tablet is undetermined. Seek medical advice.
PregnancySAFE IF PRESCRIBED
Controlled-release Dydrovian 30mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data in humans remain scarce.
Breast feedingCONSULT YOUR DOCTOR
Extended-release dydrogesterone 30mg tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a Dydrovian 30mg controlled-release tablet could reduce alertness, impair vision, and induce drowsiness or dizziness. Refrain from driving if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Dydrovian 30mg CR tablets in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Dydrovian 30mg CR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dydrovian 30mg CR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Dydrovian 30mg Tablet CR :
Should you forget a Dydrovian 30mg Controlled-Release tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dydrovian 30mg Tablet CR
| Label | Value |
|---|---|
| Chemical Type | Glucocorticoids, Mineralocorticoids, and Progestins |
| Developing Habits | No. |
| Type of Therapy | Obstetrics and Gynecology |
| Actions | First-generation progestins |
